Mastek Limited Grants 6,00,000 Stock Options to Eligible Employees Under ESOP Plans VI and VII

1 min read     Updated on 01 Apr 2026, 07:35 AM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Mastek Limited has granted 6,00,000 stock options to eligible employees under ESOP Plans VI and VII, effective April 1, 2026, with an exercise price of Rs. 1,000 per option. The options feature a performance-linked vesting schedule over 3-5 years and can be exercised within 7 years of vesting. Each option converts to one equity share with Rs. 5 face value, subject to meeting performance conditions set by the Nomination and Remuneration Committee.

powered bylight_fuzz_icon
36554728

*this image is generated using AI for illustrative purposes only.

Mastek Limited has announced the grant of 6,00,000 stock options to eligible employees under its Employee Stock Options Plans VI and VII. The Nomination and Remuneration Committee approved this grant pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and the SEBI (Share Based Employee Benefits) Regulations, 2021.

Grant Details and Pricing

The stock options grant encompasses significant details for employee compensation. The company has structured the offering with specific pricing and share parameters.

Parameter Details
Total Options Granted 6,00,000 (Six Lakhs)
Exercise Price Rs. 1,000 per Option
Face Value per Share Rs. 5
Effective Date April 1, 2026
Applicable Plans ESOP Plan VI and Plan VII

Vesting Schedule and Performance Conditions

The options follow a performance-linked vesting structure spanning multiple years. The vesting schedule allows for up to 100% of the options to vest at the end of the 3rd year from the grant date, subject to achieving performance conditions defined by the Nomination and Remuneration Committee.

If performance conditions are not met at the first vesting date, the balance unvested options will have additional opportunities to vest:

  • Second vesting opportunity: 4th year from grant date
  • Third vesting opportunity: 5th year from grant date
  • Lapse condition: All options remaining unvested after the 3rd vesting date shall lapse

Exercise Period and Regulatory Compliance

The exercise framework provides flexibility for option holders while maintaining regulatory compliance. Once vested, employees have a maximum period of 7 years from the date of vesting to exercise their options.

Compliance Aspect Status
SEBI Regulations Compliance Yes
Share Type Equity shares, fully paid up
Administration Nomination and Remuneration Committee
Regulatory Framework SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021

The stock options are governed under ESOP Plan VI and Plan VII, which are administered and implemented by the company's Nomination and Remuneration Committee. This grant represents part of Mastek's employee retention and incentive strategy, linking employee rewards to company performance through the structured vesting conditions.

Historical Stock Returns for Mastek

1 Day5 Days1 Month6 Months1 Year5 Years
+3.08%+4.01%-4.82%-31.71%-28.89%+18.49%

What specific performance metrics will Mastek use to determine whether employees meet the vesting conditions over the next three years?

How might this significant ESOP grant impact Mastek's earnings per share dilution when employees begin exercising options from 2029 onwards?

Will Mastek need to expand its existing ESOP pool or seek shareholder approval for additional share allocations to accommodate future grants?

Mastek Limited Schedules Analyst Meet with Fidelity International on March 31, 2026

1 min read     Updated on 31 Mar 2026, 03:31 AM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Mastek Limited has scheduled a virtual analyst/institutional investor meet with Fidelity International on March 31, 2026, at 3:30 PM under SEBI Regulation 30. The one-to-one interaction will focus on industry and company-specific developments already in the public domain, with the company confirming that no unpublished price sensitive information will be shared. The meeting details have been disclosed to stock exchanges and made available on the company's website.

powered bylight_fuzz_icon
36453683

*this image is generated using AI for illustrative purposes only.

Mastek Limited has announced a scheduled analyst and institutional investor meet with Fidelity International, set to take place on March 31, 2026. The company informed stock exchanges about this engagement under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015.

Meeting Details

The virtual investor interaction is structured as a single investor meet with specific parameters outlined by the company:

Parameter: Details
Date: March 31, 2026
Interaction With: Fidelity International
Nature of Meet: Single Investor Meet
Mode: Virtual
Timing: 3:30 PM
Discussion Focus: Industry/Company-specific developments already in public domain

Regulatory Compliance and Disclosure

Mastek has emphasized its commitment to regulatory compliance by clearly stating that no unpublished price sensitive information (UPSI) will be shared during the investor meet. This one-to-one investor interaction follows standard disclosure protocols required under SEBI regulations.

The company has also noted that the meeting schedule may undergo changes due to exigencies on the part of either the investor or the company. This flexibility clause is standard practice for such corporate engagements.

Information Accessibility

In line with transparency requirements, Mastek has made the meeting information available on its corporate website at www.mastek.com . This ensures that all stakeholders have access to the same information regarding the scheduled investor interaction.

The formal communication was signed by Reena Raje, Company Secretary & Compliance Officer (Membership No. A21440), and submitted to both BSE Limited and The National Stock Exchange of India Limited on March 30, 2026.

Historical Stock Returns for Mastek

1 Day5 Days1 Month6 Months1 Year5 Years
+3.08%+4.01%-4.82%-31.71%-28.89%+18.49%

Could this Fidelity International meeting signal potential institutional investment or portfolio rebalancing in Mastek's stock?

What industry-specific developments might Mastek be highlighting to attract international institutional interest?

How might increased institutional investor engagement impact Mastek's stock liquidity and valuation in the coming quarters?

More News on Mastek

1 Year Returns:-28.89%